For decades, National Institutes of Health funding has supported Michael E. Duffey, PhD, whose work has been published in top journals such as Nature.
We receive funding from a variety of sources that recognize the value of our high-impact research.
Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Michael Duffey (Co-Investigator). NIH National Eye Institute. $1,972,804. 2/1/2018-9/1/2028.
Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Mark Parker (Principal Investigator). NIH National Eye Institute. 1/1/2018-9/1/2028.
Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers. Wilma Hofmann (Co-Investigator). NIH/NCI. 8/1/2023-7/1/2028.
Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells. Zhen Yan (Principal Investigator). NINDS/NIH. $3,088,565. 2/1/2023-1/1/2028.
Transcriptomic and Circuitry Aberrations in Alzheimer’s Disease. Zhen Yan (Principal Investigator). NIA/NIH. $3,710,395. 12/1/2022-11/1/2027.
Role of epicardial adiposity as a local mediator of VT/VF dynamics in donor hearts. Kedar Aras (Principal Investigator). NIH/NHLBI. $750,000. 3/1/2023-2/1/2026.
Synaptic and Genetic Mechanisms of Sex-Specific Effects of Stress. Zhen Yan (Principal Investigator). NIMH/NIH. $2,621,841. 4/1/2021-1/1/2026.
Immunomodulatory Therapy After Resuscitation From Cardiac Arrest. Brian Weil (Principal Investigator). National Institutes of Health (NHLBI). $1,822,516. 1/1/2022-12/1/2025.
Investigating the role of NBCe1-B in renal and cardiac acid-base handling. Mark Parker (Consultant). NIH National Institute of Diabetes and Digestive and Kidney Diseases. 7/1/2020-7/1/2025.
Molecular Segregation of Parkinson’s Disease by Patient-derived Neurons. Jian Feng (Principal Investigator). NINDS/NIH. $2,244,925. 6/1/2020-5/1/2025.
Preventing and Reversing Interstitial Fibrosis in HFpEF. Brian Weil (Co-Investigator). Veteran's Affairs Merit Review Award. $709,984. 10/1/2020-9/1/2024.
Renal considerations in the heat stress and hydration recommendations. Mark Parker (Co-Investigator). NIH National Institute for Occupational Safety and Health. 9/1/2019-8/1/2024.
Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia. Zhen Yan (Principal Investigator). NIA/NIH. $2,532,180. 8/1/2019-3/1/2024.
Fluorescent peptides for probing and modulation of membrane mechanics. Thomas Suchyna (Principal Investigator). NIGMS. 4/1/2020-3/1/2023.
Investigation of Myocardial Sympathetic Denervation as a Novel Mechanism of Ischemia-Induced Pulseless Electrical Activity Cardiac Arrest. Brian Weil (Principal Investigator). The ZOLL Foundation. $47,740. 1/1/2022-12/1/2022.
Pathophysiology of Left Ventricular Stiffening in Heart Failure. Brian Weil (Principal Investigator). National Institutes of Health (NHLBI). $397,476. 9/1/2020-8/1/2022.
A Novel Epigenetic Mechanism for Alzheimer's Disease. Jian Feng (Co-Investigator). NIH. $1,993,750. 4/1/2017-3/1/2022.
Functions of parkin in Parkinson’s disease. Jian Feng (Principal Investigator). NINDS/NIH. $1,801,304. 9/1/2018-3/1/2022.
Kinetic Barriers of Transdifferentiation. Jian Feng (Principal Investigator). Department of Veterans Affairs. $833,012. 4/1/2018-3/1/2022.
The Interaction of parkin and environmental toxins in Parkinson’s disease. Jian Feng (Principal Investigator). Department of Veterans Affairs. $783,012. 3/1/2018-3/1/2022.